GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (OTCPK:IBOGF) » Definitions » Gross Profit

IBOGF (Universal Ibogaine) Gross Profit : $1.37 Mil (TTM As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine Gross Profit?

Universal Ibogaine's gross profit for the three months ended in Jan. 2025 was $0.26 Mil. Universal Ibogaine's gross profit for the trailing twelve months (TTM) ended in Jan. 2025 was $1.37 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Universal Ibogaine's gross profit for the three months ended in Jan. 2025 was $0.26 Mil. Universal Ibogaine's Revenue for the three months ended in Jan. 2025 was $0.26 Mil. Therefore, Universal Ibogaine's Gross Margin % for the quarter that ended in Jan. 2025 was N/A%.

Universal Ibogaine had a gross margin of N/A% for the quarter that ended in Jan. 2025 => No sustainable competitive advantage


Universal Ibogaine Gross Profit Historical Data

The historical data trend for Universal Ibogaine's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Gross Profit Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Gross Profit
Get a 7-Day Free Trial - - 0.83 0.78 1.70

Universal Ibogaine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.39 0.41 0.31 0.26

Competitive Comparison of Universal Ibogaine's Gross Profit

For the Biotechnology subindustry, Universal Ibogaine's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Gross Profit distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Gross Profit falls into.


;
;

Universal Ibogaine Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Universal Ibogaine's Gross Profit for the fiscal year that ended in Jul. 2024 is calculated as

Gross Profit (A: Jul. 2024 )=Revenue - Cost of Goods Sold
=1.7 - 0
=1.70

Universal Ibogaine's Gross Profit for the quarter that ended in Jan. 2025 is calculated as

Gross Profit (Q: Jan. 2025 )=Revenue - Cost of Goods Sold
=0.259 - 0
=0.26

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.37 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Universal Ibogaine's Gross Margin % for the quarter that ended in Jan. 2025 is calculated as

Gross Margin % (Q: Jan. 2025 )=Gross Profit (Q: Jan. 2025 ) / Revenue (Q: Jan. 2025 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.26 / 0.259
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Universal Ibogaine  (OTCPK:IBOGF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Universal Ibogaine had a gross margin of N/A% for the quarter that ended in Jan. 2025 => No sustainable competitive advantage


Universal Ibogaine Gross Profit Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.